These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30483352)
1. Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation. Sun K; Sanchez CG; Pingali SR; Iyer S Ecancermedicalscience; 2018; 12():872. PubMed ID: 30483352 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation. Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292 [TBL] [Abstract][Full Text] [Related]
3. Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report. Wang XT; Guo W; Sun M; Han W; Du ZH; Wang XX; Du BB; Bai O World J Clin Cases; 2020 Jul; 8(14):3122-3129. PubMed ID: 32775395 [TBL] [Abstract][Full Text] [Related]
4. [Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation for Treating Patient with Primary Cutaneous γΔ T Cell Lymphoma]. Wei ZL; Huang LQ; Dai Y; Su GP; Jiang YZ; Huang DP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):749-54. PubMed ID: 27342503 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Yabe M; Medeiros LJ; Tang G; Wang SA; Ahmed S; Nieto Y; Hu S; Bhagat G; Oki Y; Patel KP; Routbort M; Luthra R; Fanale MA; Bueso-Ramos CE; Jorgensen JL; Vega F; Chen W; Hoehn D; Konoplev S; Milton DR; Wistuba I; Li S; You MJ; Young KH; Miranda RN Am J Surg Pathol; 2016 May; 40(5):676-88. PubMed ID: 26872013 [TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma. Jeon Y; Yoon SE; Cho J; Kim SJ; Kim WS Ann Hematol; 2023 Jul; 102(7):1867-1877. PubMed ID: 37188978 [TBL] [Abstract][Full Text] [Related]
7. Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults. McThenia SS; Rawwas J; Oliveira JL; Khan SP; Rodriguez V Pediatr Transplant; 2018 Aug; 22(5):e13213. PubMed ID: 29921021 [TBL] [Abstract][Full Text] [Related]
8. Role of Imaging in Diagnosis of a Rare Hepatosplenic Gamma Delta T-Cell Lymphoma during Pregnancy: A Case Report and Review of Literature. Youssef RRH; Elmahdy A; Kohla S; Ibrahim F; Sabry AS; Alobaidly A; Saloum N Case Rep Oncol; 2019; 12(3):935-943. PubMed ID: 31966031 [TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
10. L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Nagafuji K; Fujisaki T; Arima F; Ohshima K Int J Hematol; 2001 Dec; 74(4):447-50. PubMed ID: 11794702 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation. Prochazka V; Faber E; Raida L; Papajik T; Vondrakova J; Rusinakova Z; Kucerova L; Myslivecek M; Indrak K Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):63-9. PubMed ID: 21475380 [TBL] [Abstract][Full Text] [Related]
12. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma. Chanan-Khan A; Islam T; Alam A; Miller KC; Gibbs J; Barcos M; Czuczman MS; Paplham P; Hahn T; McCarthy P Leuk Lymphoma; 2004 Aug; 45(8):1673-5. PubMed ID: 15370223 [TBL] [Abstract][Full Text] [Related]
13. Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma. Catania G; Zallio F; Monaco F; Corsetti MT; Trincheri N; Bonello L; Mele L; Dallavalle F; Salvi F; Pini M Leuk Res Rep; 2014; 3(2):90-3. PubMed ID: 25429355 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature. Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893 [TBL] [Abstract][Full Text] [Related]
15. Hepatosplenic and other gammadelta T-cell lymphomas. Vega F; Medeiros LJ; Gaulard P Am J Clin Pathol; 2007 Jun; 127(6):869-80. PubMed ID: 17509984 [TBL] [Abstract][Full Text] [Related]
16. Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation. Steurer M; Stauder R; Grünewald K; Gunsilius E; Duba HC; Gastl G; Dirnhofer S Hum Pathol; 2002 Feb; 33(2):253-8. PubMed ID: 11957154 [TBL] [Abstract][Full Text] [Related]
17. Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges. Gentille C; Qin Q; Barbieri A; Ravi PS; Iyer S Ecancermedicalscience; 2017; 11():771. PubMed ID: 29062389 [TBL] [Abstract][Full Text] [Related]
18. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259 [TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review. Ochenrider MG; Patterson DJ; Aboulafia DM Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features. Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]